Brokerages Set Allogene Therapeutics, Inc. (NASDAQ:ALLO) Target Price at $8.44
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) has been given an average rating of “Moderate Buy” by the ten brokerages that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 1 year […]
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) has been given an average rating of “Moderate Buy” by the ten brokerages that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 1 year […]
